REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Siris Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Siris Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Siris Limited is a company based in India, with its head office in Guntur. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on December 16, 1966. The total number of employees is currently 2 (2025). There was a total growth of 2.73% in Siris Limited’s total assets over the same period.

Legal Address
Flat No.209, A Block, Sri Chakara Residency,Navodaya Colony
Guntur; Andhra Pradesh; Postal Code: 522501

Contact Details: Purchase the Siris Limited report to view the information.

Basic Information
Total Employees:
Purchase the Siris Limited report to view the information.
Outstanding Shares:
Purchase the Siris Limited report to view the information.
Registered Capital:
Purchase the Siris Limited report to view the information.
Financial Auditors:
Purchase the Siris Limited report to view the information.
Incorporation Date:
December 16, 1966
Key Executives
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Sudershan Drugs & Intermediates Ltd.
Company Performance
Financial values in the chart are available after Siris Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Total Operating Revenue
84.25%▲
Operating Profit
134.68%▲
EBITDA
134.06%▲
Net Profit/Loss for the Period
94.28%▲
Total Assets
2.73%▲
Total Equity
8.49%▲
Return on Equity (ROE)
3.45%▲
Debt / Equity
3.49%▲
Quick Ratio
-0.26%▼
Cash Ratio
-0.46%▼

Similar companies

Sun Pharmaceutical Industries Ltd.
 
Dr. Reddy's Laboratories Ltd.
Aurobindo Pharma Ltd.
 
Cipla Ltd.
Zydus Lifesciences Ltd.
 
Lupin Ltd.
Progenerics Pharma Private Limited
 
Reddy Pharmaceuticals Limited
Triochem Products Ltd.
 
Transgene Biotek Ltd.
Pioneer Bio-Pharma Private Limited
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo